1-13 of 13
Tobias Dittrich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study

Eli Muchtar, Giovanni Palladini, Stefan Schonland, Angela Dispenzieri, Brendan Wisniowski, Giampaolo Merlini, Paolo Milani, Ute Hegenbart, Tobias Dittrich, Efstathios Kastritis, Meletios Athanasios Dimopoulos, Vaishali Sanchorawala, Raphael E Szalat, Michaela Liedtke, Mani Gupta, Heather Landau, Suzanne Lentzsch, Michael Sang Hughes, Maria Teresa Cibeira López, Joan Bladé, Shaji Kunnathu Kumar, Ashutosh D. Wechalekar, Morie A Gertz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3411.
https://doi.org/10.1182/blood-2023-190226
Published: 2023
Journal Articles

Two-Year Evaluation of the German Clinical Amyloidosis Registry

Ute Hegenbart, Niklas Fuhr, Laura Huber, Christoph Kimmich, Kaya Veelken, Tobias Dittrich, Rita Ziehl, Fabian aus dem Siepen, Alexander Carpinteiro, Timon Hansen, Carsten Müller-Tidow, Axel Benner, Stefan Schönland
Journal: Blood
Blood (2021) 138 (Supplement 1): 3780.
https://doi.org/10.1182/blood-2021-152713
Published: 2021
Journal Articles

Multi-Modality Imaging Reveals Structural Centrosome Aberrations As a Potential Driver of Chromosomal Instability in Early-Stage Plasma Cell Disorders

Sebastian Köhrer, Tobias Dittrich, Martin Schorb, Niels Weinhold, Isabella Haberbosch, Mandy Börmel, Gabor Pajor, Hartmut Goldschmidt, Carsten Müller-Tidow, Marc-Steffen Raab, Alexander Brobeil, Peter Dreger, Ute Hegenbart, Stefan Schönland, Yannick Schwab, Alwin Krämer
Journal: Blood
Blood (2021) 138 (Supplement 1): 1579.
https://doi.org/10.1182/blood-2021-150747
Published: 2021
Journal Articles

Gain 1q21 Is an Adverse Prognostic Factor in Patients with Relapsed/Refractory AL Amyloidosis Treated with Lenalidomide and Dexamethasone

Marco Basset, MD, Christoph Kimmich, Tobias Dittrich, MD, Kaya Veelken, MD, Hartmut Goldschmidt, MD, Dirk Hose, MD, Anja Seckinger, MD, Anna Jauch, Carsten Mueller-Tidow, MD, Ute Hegenbart, MD, Stefan Schönland, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-142701
Published: 2020
Journal Articles

Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria

Clinical Trials & Observations
Christoph R. Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinteiro, Timon Hansen, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Anna Jauch, Stefan Wörner, Jörg Beimler, Carsten Müller-Tidow, Ute Hegenbart, Stefan O. Schönland
Journal: Blood
Blood (2020) 135 (18): 1517–1530.
https://doi.org/10.1182/blood.2019003633
Published: 2020
Includes: Supplemental data
Journal Articles

High-Throughput Immunofluorescence and Electron Tomography to Characterize Centrosomal Aberrations in Plasma Cell Neoplasia

Tobias Dittrich, MD, Martin Schorb, Isabella Haberbosch, MD, Elena Bausch, PhD, Mandy Börmel, Marco Cosenza, PhD, Hartmut Goldschmidt, MD, Carsten Müller-Tidow, MD, Marc S Raab, MD PhD, Ute Hegenbart, MD, Stefan O. Schönland, MD, Yannick Schwab, PhD, Alwin Krämer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3077.
https://doi.org/10.1182/blood-2019-130713
Published: 2019
Journal Articles

A Semi-Automated Knime-Based Workflow for High Throughput Quantification and Analysis of Centrosome Aberrations

Tobias Dittrich, MD, Elena Bausch, PhD, Johannes Bausch, PhD, Hartmut Goldschmidt, MD, Ute Hegenbart, MD, Stefan O. Schönland, MD, Marc S Raab, MD PhD, Alwin Krämer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3379.
https://doi.org/10.1182/blood-2019-129863
Published: 2019
Journal Articles

Treatment of AL amyloidosis with bendamustine: a study of 122 patients

Clinical Trials & Observations
Paolo Milani, Stefan Schönland, Giampaolo Merlini, Christoph Kimmich, Andrea Foli, Tobias Dittrich, Marco Basset, Carsten Müller-Tidow, Tilmann Bochtler, Giovanni Palladini, Ute Hegenbart
Journal: Blood
Blood (2018) 132 (18): 1988–1991.
https://doi.org/10.1182/blood-2018-04-845396
Published: 2018
Includes: Supplemental data
Journal Articles

Safety and Efficacy of Deferred Autologous Stem Cell Transplantation in Patients with Systemic AL Amyloidosis with Significant Cardiac Involvement at Presentation

Richa Manwani, MBBS, FRCPath, BSc, Ute Hegenbart, Darren Foard, Shameem Mahmood, Sajitha Sachchithanantham, BSc,FRCPath,MBBS,MRCP, Kwee Yong, PhD, Rakesh Popat, MD PhD, Charalampia Kyriakou, MD PhD, Neil Rabin, Marianna Fontana, Carol Whelan, Helen Lachmann, Thirusha Lane, Candida Quarta, Julian Gillmore, Tobias Dittrich, MD, Christoph Kimmich, MD, Philip Hawkins, Stefan Schönland, MD, Ashutosh D. Wechalekar, MBBS,FRCP,FRCPath,DM
Journal: Blood
Blood (2017) 130 (Supplement 1): 1815.
https://doi.org/10.1182/blood.V130.Suppl_1.1815.1815
Published: 2017
Journal Articles

Daratumumab Monotherapy in Thirty-Two Heavily Pre-Treated Patients with Advanced Systemic Light-Chain Amyloidosis

Christoph Kimmich, MD, Stefan Schönland, MD, Rita Ziehl, Anthony D. Ho, Tobias Dittrich, MD, Carsten Müller-Tidow, Ute Hegenbart
Journal: Blood
Blood (2017) 130 (Supplement 1): 1837.
https://doi.org/10.1182/blood.V130.Suppl_1.1837.1837
Published: 2017
Journal Articles

AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis

Tobias Dittrich, Tilmann Bochtler, Christoph Kimmich, Natalia Becker, Anna Jauch, Hartmut Goldschmidt, Anthony D. Ho, Ute Hegenbart, Stefan O. Schönland
Journal: Blood
Blood (2017) 130 (5): 632–642.
https://doi.org/10.1182/blood-2017-02-767475
Published: 2017
Includes: Supplemental data
Journal Articles

Clinical and Cytogenetic Characterization of Light Chain Amyloidosis Patients with a Low Amyloidogenic Free Light Chain Count at First Diagnosis

Tobias Dittrich, MD, Ute Hegenbart, MD, Tilmann Bochtler, MD, Christoph Kimmich, MD, Anna Jauch, Prof., Arnt Kristen, MD, Hartmut Goldschmidt, MD, Anthony D. Ho, MD, Stefan Schönland, MD
Journal: Blood
Blood (2015) 126 (23): 1790.
https://doi.org/10.1182/blood.V126.23.1790.1790
Published: 2015
Journal Articles

Minimal Renal Toxicity after Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Katharina Lisenko, MD, Fabienne McClanahan, MD PhD, Tilman Schöning, MD, Mark-Alexander Schwarzbich, MD, Martin Cremer, MD, Tobias Dittrich, MD, Anthony D. Ho, MD, Mathias Witzens-Harig, MD
Journal: Blood
Blood (2015) 126 (23): 1506.
https://doi.org/10.1182/blood.V126.23.1506.1506
Published: 2015